YNBY International Limited (0030) Fair Value & Analysis
Financial Services · HK · Market cap HK$2.4B
Fair value as of: Aug 7, 2026
From 17 valuation models · updated today
Fair value updated Aug 7, 2026, revised from HK$0.0100 to HK$0.4500 (+4,400.0%) since Aug 2, 2026. Share price −8.9% over the past month.
Below-average quality, screening 83% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (33/100). That raises the risk this is a value trap rather than a bargain.
- The model range is unusually wide (HK$0.2400 to HK$0.6400). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 7, 2026.
How to read this chart
60‑month range HK$0.0680 – HK$0.5600 · fair‑value band HK$0.2400 – HK$0.6400 · the HK$0.2460 price screens below the HK$0.4500 fair value. Dashed = 300-day average. As of Aug 7, 2026.
Analysis
YNBY International Limited (0030) currently trades at HK$0.2460, while our model-based Fair Value estimate is HK$0.4500, implying the stock looks roughly 82.9% undervalued today. We read business quality at 33/100 (below-average quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, YNBY International Limited generated revenue of HK$1.1B at a net margin of 0.4%. Revenue grew 81.3% year over year. It earns a return on equity of 1.5%. The balance sheet holds a net cash position of HK$190M. Fundamentals as of Aug 7, 2026
Our scenario range runs from HK$0.2400 (bear case) to HK$0.6400 (bull case); at HK$0.2460, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 25% below its 52-week high and 36% above its 52-week low, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 11% fair-value upside, at 83%, 0030 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 17 models by family
Widest divergence: Dividend Discount (HK$9.68) versus Earnings-Based (HK$0.2250). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 7, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 32 · Market factors (momentum, volatility) 46
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
YNBY International Limited, an investment holding company, engages in the e-commerce and general trading business in Hong Kong, the People's Republic of China, and internationally.
Full company description
YNBY International Limited, an investment holding company, engages in the e-commerce and general trading business in Hong Kong, the People's Republic of China, and internationally. It is involved in the raw materials trading business for healthcare products, including sourcing of packaging materials, pharmacy and cosmetics materials, plant extracts, etc.; and manufacturing of cosmetics and healthcare products, as well as related packaging materials. The company also supplies other plant extracts and raw materials comprising packaging materials for the healthcare and cosmetics industry; and offers marketing services, product and intellectual property registration services, and sourcing services for original equipment manufacturers (OEM)/ original design manufactures (ODM). In addition, it provides overseas marketing and overseas market expansion services. YNBY International Limited also manufactures toothpaste products under the brand name of Yunnan Baiyao manufactured in Thailand. The company was formerly known as Ban Loong Holdings Limited and changed its name to YNBY International Limited in September 2023. YNBY International Limited was founded in 1971 and is based in Quarry Bay, Hong Kong.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
YNBY International Limited reported revenue of HK$1.1B in FY2026 versus HK$180M in FY2022, a compound +57.6%/yr. Reported net income was HK$4.6M in FY2026.
Watch 0030: get an alert when its fair value changes →
Peer Group
Capital Markets · 426 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Capital Markets median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Capital Markets stocks, each showing price versus our Fair Value estimate (as of Aug 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Huatai Securities Co HTSC | $0.2700 | $0.0400 | -85% |
| Mirae Asset Securities Co 006800 | 38,750 KRW | 31,645 KRW | -18% |
| Meritz Financial Group 138040 | 117,000 KRW | 87,706 KRW | -25% |
| Korea Investment Holdings 071050 | 239,000 KRW | 318,825 KRW | +33% |
| NH Investment & Securities Co 005940 | 31,000 KRW | 37,133 KRW | +20% |
| Samsung Securities Co 016360 | 107,700 KRW | 126,487 KRW | +17% |
| Motilal Oswal Financial Services Limited MOTILALOFS | ₹967.00 | ₹299.65 | -69% |
| Kiwoom Securities Co 039490 | 322,000 KRW | 358,091 KRW | +11% |
| SSI Securities Corporation SSI | 24,250 VND | 28,021 VND | +16% |
| Bolsas y Mercados Argentinos S.A BYMA | 313.75 ARS | 120.22 ARS | -62% |
Compare YNBY International Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is YNBY International Limited (0030) overvalued or undervalued?
What is the fair value of 0030?
What is the quality score of 0030?
What is the revenue of YNBY International Limited (0030)?
What is the net profit margin of 0030?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track YNBY International Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.